Try out PMC Labs and tell us what you think. Learn More.

Logo of archdischArchives of Disease in ChildhoodVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Arch Dis Child. 1998 Mar; 78(3): 273–274.
PMCID: PMC1717498
PMID: 9613364

Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine

Abstract

Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against polio, diphtheria, and tetanus) did not cause relapse of thrombocytopenia.

Full Text

The Full Text of this article is available as a PDF (51K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Herroelen L, de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet. 1991 Nov 9;338(8776):1174–1175. [PubMed] [Google Scholar]
  • Lilic D, Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet. 1994 Nov 5;344(8932):1292–1293. [PubMed] [Google Scholar]
  • Martínez E, Domingo P. Evans's syndrome triggered by recombinant hepatitis B vaccine. Clin Infect Dis. 1992 Dec;15(6):1051–1051. [PubMed] [Google Scholar]
  • Poullin P, Gabriel B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet. 1994 Nov 5;344(8932):1293–1293. [PubMed] [Google Scholar]
  • Tazzari PL, Ricci F, Vianelli N, Tassi C, Belletti D, Pierri I, Gugliotta L, Gobbi M, Conte R. Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. Ann Hematol. 1995 May;70(5):267–272. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group